According to the results of flow cytometry, MTT and immunofluorescence assays, the cell proliferation ability, cell viability and proliferation cell nuclear antigen (PCNA) positive rate were significantly enhanced in RA‐FLSs compared with FLSs, while treatment with Evs reversed these changes (Figure 3D‐F). The gene discussed is PCNA; the disease is rheumatoid arthritis.